Prostatis Group’s Schwab US Large-Cap Growth ETF SCHG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Sell
44,238
-155,545
-78% -$4.84M 0.33% 68
2025
Q4
$6.52M Buy
199,783
+29,289
+17% +$953K 1.56% 12
2025
Q3
$5.44M Sell
170,494
-129,534
-43% -$3.95M 1.36% 16
2025
Q2
$8.76M Buy
+300,028
New +$7.93M 2.51% 8
2022
Q1
Sell
-20,368
Closed -$417K 95
2021
Q4
$417K Buy
+20,368
New +$407K 0.26% 59

Other funds holding SCHG

Prostatis Group's SCHG Position: Q1 2026 in Review

Prostatis Group reduced its Schwab US Large-Cap Growth ETF (SCHG) stake by 78% in Q1 2026, selling an estimated $4.84M and leaving 44,238 shares worth $1.29M. The position accounts for 0.33% of the portfolio, ranked #68.

Prostatis Group first reported a position in SCHG in Q4 2021 and has held it in 5 quarters since. The position peaked at $8.76M in Q2 2025. 1,614 funds tracked by Wall St. Rank hold SCHG as of Q1 2026.

  • Prostatis Group held 44,238 shares of Schwab US Large-Cap Growth ETF worth $1.29M as of Q1 2026.
  • Prostatis Group sold 155,545 Schwab US Large-Cap Growth ETF shares in Q1 2026, an estimated $4.84M.
  • Schwab US Large-Cap Growth ETF made up 0.33% of Prostatis Group's portfolio in Q1 2026, its #68 holding.
  • Prostatis Group first reported a position in Schwab US Large-Cap Growth ETF in Q4 2021 and has held it in 5 quarters since.
  • Prostatis Group's Schwab US Large-Cap Growth ETF position peaked at $8.76M in Q2 2025.
  • 1,614 funds tracked by Wall St. Rank held Schwab US Large-Cap Growth ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.